FIT Biotech Oy (FIT Biotech), formerly Finnish Immunotechnology Oy, is a clinical stage biotechnology company which develops and commercializes antibody gene delivery technologies and gene vaccines for cancer immunotherapy and treatment of HIV. The company develops DNA based products using its patented gene delivery technology to control the progression to AIDS in HIV infected individuals. Its gene transfer unit has applications in DNA vaccination and immune therapy. The company also develops recombinant proteins, diagnostic products, artificial immunogens and antibody technologies, and tuberculosis vaccine. It has in-house drug development projects and collaborative projects with other international biotech companies, pharmaceutical companies and academic research institutions. FIT Biotech is headquartered in Tampere, Finland.
FIT Biotech Oy Key Recent Developments
Jan 18, 2018: FIT Biotech’s CEO to change - Erkki Pekkarinen appointed as a new CEO
Jan 18, 2018: FIT Biotech Oy Announces Senior Management Changes
Sep 15, 2017: Fit Biotech Half-yearly Financial Report January 1 - June 30, 2017
Aug 23, 2017: FIT Biotech Oy: FIT Biotech Board elected Erkki Pekkarinen to the Deputy Chairman of the Board
Jul 12, 2017: FIT Biotech Receives EUR 644,868 Payment from European HIV Vaccine Alliance
This comprehensive SWOT profile of FIT Biotech Oy provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of FIT Biotech Oy including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
- FIT Biotech Oy - Key Information
- FIT Biotech Oy - Overview
- FIT Biotech Oy - Key Employees
- FIT Biotech Oy - Key Employee Biographies
- FIT Biotech Oy - Key Operational Heads
- FIT Biotech Oy - Major Products and Services
- FIT Biotech Oy - History
- FIT Biotech Oy - Company Statement
- FIT Biotech Oy - Locations And Subsidiaries
- FIT Biotech Oy - Key Manufacturing facilities
- Head Office
- Other Locations & Subsidiaries
- FIT Biotech Oy - Business Description
- FIT Biotech Oy - Corporate Strategy
- FIT Biotech Oy - SWOT Analysis
- SWOT Analysis - Overview
- FIT Biotech Oy - Strengths
- FIT Biotech Oy - Weaknesses
- FIT Biotech Oy - Opportunities
- FIT Biotech Oy - Threats
- FIT Biotech Oy - Key Competitors
- FIT Biotech Oy - Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Ratio Definitions
List of Tables
- FIT Biotech Oy, Key Information
- FIT Biotech Oy, Key Ratios
- FIT Biotech Oy, Share Data
- FIT Biotech Oy, Major Products and Services
- FIT Biotech Oy, History
- FIT Biotech Oy, Key Employees
- FIT Biotech Oy, Key Employee Biographies
- FIT Biotech Oy, Key Operational Heads
- FIT Biotech Oy, Other Locations
- FIT Biotech Oy, Subsidiaries
- FIT Biotech Oy, Key Manufacturing facilities
- FIT Biotech Oy, Key Competitors
- FIT Biotech Oy, SWOT Analysis
- FIT Biotech Oy, Ratios based on current share price
- FIT Biotech Oy, Annual Ratios
- FIT Biotech Oy, Interim Ratios
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- FIT Biotech Oy, Performance Chart
- FIT Biotech Oy, Ratio Charts